StockTipsArenaBeta

BUY Akums Drugs and Pharmaceuticals — Anand James, Geojit Investments

BUYAkums Drugs and Pharmaceuticals
Akums Drugs and Pharmaceuticals share price target & all analyst calls

byAnand James, Geojit InvestmentsHorizon: NA (inferred Swing (≤2wk))22 Sept 2026via Business Standard Markets

Entry₹821Stated
Target₹860
Total upside +4.75% (call closed)
Stop loss₹803-2.19% risk
Exit₹80328 Sept 2026, 1:35 pm
Stop-loss hit-2.19%
Follow Anand James for new callsGet alertsWatch AKUMS for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Sept 2026
3 supporting1 neutral0 opposing
Supports the BUY call (3)

Akums Announces DCGI-Approved Triple Therapy for H. pylori Infection

NewsGoogle News·21 Sept · 1w ago

(opens in new tab)

Akums Share Price today near 52-week high on 2.72% rise

NewsGoogle News·18 Sept · 1w ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·15 Sept · 2w ago

Neutral / worth noting (1)

Akums Drugs to Host Analyst and Investor Meeting on September 22

NewsGoogle News·16 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Akums Drugs and Pharmaceuticals

All analyst calls on Akums Drugs and Pharmaceuticals

More from Anand James, Geojit Investments

Every call and its outcome